NYSE · Healthcare
Avantor, Inc. (AVTR)
As-reported financials and recent SEC filings for Avantor, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$6.55B
Net income
$-530.2M
Net margin
-8.1%
Diluted EPS
$-0.78
ROE
-9.5%
P/E (TTM)
—
Market cap
$7.02B
Debt / equity
0.7×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $6.55B | $6.78B | $6.97B | $7.51B | $7.39B |
| Gross profit | $2.14B | $2.28B | $2.36B | $2.60B | $2.50B |
| Operating income | $-246.2M | $1.08B | $696.4M | $1.13B | $972.2M |
| Net income | $-530.2M | $711.5M | $321.1M | $686.5M | $572.6M |
| Diluted EPS | $-0.78 | $1.04 | $0.47 | $1.01 | $0.85 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-22
View on EDGAR →SD2026-05-29
View on EDGAR →8-K2026-05-12
View on EDGAR →42026-05-11
View on EDGAR →42026-05-11
View on EDGAR →42026-05-11
View on EDGAR →42026-05-11
View on EDGAR →42026-05-11
View on EDGAR →Go deeper on AVTR
Search Avantor, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.